Positively Impact Cytopathology
Advanced digital cytology can transform laboratory workflows, enhance quality of care, and reduce needless expenses. What are you waiting for?
Our AI-based solutions are currently focused on diverse application areas. Explore, then contact us for a deeper dive including a personalized demonstration.
Schedule Your Personalized Demo
AIxURO for Urine Cytology: Bladder Cancer
A bladder cancer diagnosis can be devastating. And this cancer is more common than many may realize.
- Some bladder cancers are prone to recurrence and progression
- Long-term surveillance is necessary
- Invasive, potentially painful cystoscopies may trigger patient anxiety and delay timely monitoring and treatment
- High treatment costs over lifetime
As part of a diagnostic or surveillance strategy, AIxURO from AIxMed helps to detect suspicious and atypical cells using non-invasive voided urine samples.
- 1st commercial application
- Currently available for Research Use Only (RUO) in the United States
- Quantitative scoring across whole samples based on The Paris System (TPS) approach
- Ideal for use with exfoliative, voided samples
About Our AI Technology
AIxURO accurately identifies suspicious and atypical cells using a non-invasive urine sample.
- Patients may be spared the need for frequent cystoscopies
- Reduced cystoscopy frequency may increase timely compliance with recommended care and treatment plans
- Reduced cystoscopy frequency also helps to decrease overall healthcare costs for significant payer cost savings
AIxTHY for Thyroid Cytology: Thyroid Cancer
Fine-Needle Aspiration Cytology (FNAC) is the gold standard tool to aid in distinguishing between malignant and benign thyroid nodules. Unfortunately, thyroid biopsies do not always offer a definitive cytological diagnosis.
- Overdiagnosis may result in unnecessary procedures
- Unwarranted procedures and complications increase healthcare costs
- Invasive surgeries may trigger patient anxiety
As part of a diagnostic strategy, AIxTHY from AIxMed helps to detect suspicious and atypical cells using samples collected using fine needle aspiration techniques.
- In development and soon available for Research Use Only (RUO) in the United States
- Quantitative scoring across whole samples based on the Bethesda System for the Reporting of Thyroid Cytopathology (TBSRTC)
- Ideal for use with current FNAC methods
About Our AI Technology
AIxPAP for Cervical Cytology: Cervical Cancer
Cervical cancer is one of the most preventable types of cancer, yet it remains a public health problem and a very personal journey.
- Cervical cancer rates are dropping due to proactive screening and the HPV vaccine
- Additional steps can further diminish this dreadful disease
AIxPAP from AIxMed helps to detect suspicious and atypical cells using minimally invasive abrasive techniques that are familiar to most patients.
- In development and soon available for Research Use Only (RUO) in the United States
- Ideal for use with samples collected via a standard cervical swab or brush
About Our AI Technology
